Literature DB >> 22200008

Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.

Jae-Won Jang1, Jung-Kil Lee, Soo-Han Kim.   

Abstract

OBJECTIVE: Matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9 have been known to play an important role in secondary inflammatory reaction after spinal cord injury (SCI). The aim of this study was to investigate the expression and activity of MMP-2 and MMP-9 and to determine their relationship with disruption of endothelial blood-barrier after photochemically induced SCI in rats.
METHODS: Female Sprague-Dawley rats, weighing between 250 and 300 g (aged 8 weeks) received focal spinal cord ischemia by photothrombosis using Rose Bengal. Expressions and activities of MMP-2 and MMP-9 were assessed by Western blot and gelatin zymography at various times from 6 h to 7 days. Endothelial blood-barrier integrity was assessed indirectly using spinal cord water content.
RESULTS: Zymography and Western blot analysis demonstrated rapid up-regulation of MMP-9 protein levels in spinal cord after ischemic onset. Expressions and activities of MMP-9 showed a significant increased at 6 h after the photothrombotic ischemic event, and reached a maximum level at 24 h after the insult. By contrast, activated MMP-2 was not detected at any time point in either the experimental or the control groups. When compared with the control group, a significant increase in spinal cord water content was detected in rats at 24 h after photothrombotic SCI.
CONCLUSION: Early up-regulation of MMP-9 might be correlated with increased water content in the spinal cord at 24 h after SCI in rats. Results of this study suggest that MMP-9 is the key factor involved in disruption of the endothelial blood-barrier of the spinal cord and subsequent secondary damage after photothrombotic SCI in rats.

Entities:  

Keywords:  Endothelial blood-barrier; Matrix metalloproteinases-9; Photothrombosis; Rat; Spinal cord injury

Year:  2011        PMID: 22200008      PMCID: PMC3243829          DOI: 10.3340/jkns.2011.50.4.288

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  29 in total

1.  Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke.

Authors:  Jong Eun Lee; Yone Jung Yoon; Michael E Moseley; Midori A Yenari
Journal:  J Neurosurg       Date:  2005-08       Impact factor: 5.115

2.  Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury.

Authors:  S K Agrawal; M G Fehlings
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 3.  Targeting the host inflammatory response in traumatic spinal cord injury.

Authors:  John R Bethea; W Dalton Dietrich
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

Review 4.  Matrix metalloproteinases in neuroinflammation.

Authors:  Gary A Rosenberg
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

Review 5.  Degenerative and regenerative mechanisms governing spinal cord injury.

Authors:  Christos Profyris; Surindar S Cheema; DaWei Zang; Michael F Azari; Kristy Boyle; Steven Petratos
Journal:  Neurobiol Dis       Date:  2004-04       Impact factor: 5.996

6.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

Authors:  S Mun-Bryce; G A Rosenberg
Journal:  Am J Physiol       Date:  1998-05

Review 7.  Matrix metalloproteinases in brain injury.

Authors:  G A Rosenberg
Journal:  J Neurotrauma       Date:  1995-10       Impact factor: 5.269

8.  Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological, and neurochemical results.

Authors:  D Liu; R Yang; X Yan; D J McAdoo
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

9.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

Authors:  G A Rosenberg; E Y Estrada; J E Dencoff
Journal:  Stroke       Date:  1998-10       Impact factor: 7.914

10.  Photochemically induced cerebral infarction. II. Edema and blood-brain barrier disruption.

Authors:  W D Dietrich; R Busto; B D Watson; P Scheinberg; M D Ginsberg
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more
  6 in total

1.  Effects of hyperbaric oxygen on glucose-regulated protein 78 and c-Jun N-terminal kinase expression after spinal cord injury in rats.

Authors:  Xuehua Liu; Chunsheng Li; Fang Liang; Yong Wang; Zhuo Li; Jing Yang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Intrathecal administration of naringenin improves motor dysfunction and neuropathic pain following compression spinal cord injury in rats: relevance to its antioxidant and anti-inflammatory activities.

Authors:  Sajad Fakhri; Shahryar Sabouri; Amir Kiani; Mohammad Hosein Farzaei; Khodabakhsh Rashidi; Ahmad Mohammadi-Farani; Ehsan Mohammadi-Noori; Fatemeh Abbaszadeh
Journal:  Korean J Pain       Date:  2022-07-01

3.  Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury.

Authors:  A Moghaddam; R Heller; V Daniel; T Swing; M Akbar; H-J Gerner; B Biglari
Journal:  Spinal Cord       Date:  2016-07-05       Impact factor: 2.772

4.  Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats.

Authors:  Xiao-Qian Li; Xue-Zhao Cao; Jun Wang; Bo Fang; Wen-Fei Tan; Hong Ma
Journal:  Mol Brain       Date:  2014-09-04       Impact factor: 4.041

Review 5.  Hyperbaric oxygen therapy of spinal cord injury.

Authors:  Nitesh P Patel; Jason H Huang
Journal:  Med Gas Res       Date:  2017-06-30

6.  Downregulation of Matrix Metalloproteinases 2 and 9 is Involved in the Protective Effect of Trehalose on Spinal Cord Injury.

Authors:  Masoumeh Mirzaie; Mehrnaz Karimi; Hossein Fallah; Mohammad Khaksari; Mahdieh Nazari-Robati
Journal:  Int J Mol Cell Med       Date:  2018-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.